A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes

Medicina y ciencias biológicas

• Candidemia 100%
• Peru 91%
• Candida 74%
• Fluconazole 50%
• Anidulafungin 45%
• posaconazole 41%
• Voriconazole 36%
• Incidence 35%
• Infections 34%
• Amphotericin B 32%
• Candida parapsilosis 19%
• Total Parenteral Nutrition 17%
• Microbiology 15%
• Candida albicans 14%
• Mortality 14%
• Artificial Respiration 13%
• Developing Countries 13%
• Medical Records 12%
• Epidemiology 11%
• Survival 8%

Agricultura y biología

• Candida 78%
• Peru 74%
• blood flow 69%
• fluconazole 59%
• geographical distribution 57%
• incidence 51%
• anidulafungin 50%
• infection 38%
• amphotericin B 36%
• medical records 21%
• total parenteral nutrition 20%
• Candida parapsilosis 20%
• microbiology 16%
• Candida albicans 15%
• minimum inhibitory concentration 14%
• surgery 14%
• developing countries 13%
• epidemiology 13%
• dosage 7%
• testing 5%

Compuestos químicos

• Fluconazole 98%
• Anidulafungin 94%
• Posaconazole 83%
• Voriconazole 78%
• Amphotericin B 64%
• Mechanical Ventilation 45%
• Parenteral 31%
• Resistance 15%